Vonoprazan + Lansoprazole

Phase 3Completed

0 views this week 0 watching💤 Quiet

Interest: 34/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Erosive Esophagitis

Conditions

Erosive Esophagitis

Trial Timeline

Oct 28, 2019 → Aug 24, 2021

NCT ID

NCT04124926

About Vonoprazan + Lansoprazole

Vonoprazan + Lansoprazole is a phase 3 stage product being developed by Phathom Pharmaceuticals for Erosive Esophagitis. The current trial status is completed. This product is registered under clinical trial identifier NCT04124926. Target conditions include Erosive Esophagitis.

What happened to similar drugs?

6 of 12 similar drugs in Erosive Esophagitis were approved

Approved (6) Terminated (0) Active (6)

✅Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenoneEisaiApproved

✅Esomeprazole + LansoprazoleAstraZenecaApproved

✅Esomeprazole + EsomeprazoleAstraZenecaApproved

✅esomeprazole magnesium (oral medication)AstraZenecaApproved

✅Omeprazole/sodium bicarbonateBausch HealthApproved

🔄E3810 + E3810 + PlaceboEisaiPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04729101	Phase 1	Completed	Jan 28, 2021	Jun 26, 2021	Healthy Participants
NCT04124926	Phase 3	Completed	Oct 28, 2019	Aug 24, 2021	Erosive Esophagitis

Competing Products

20 competing products in Erosive Esophagitis

See all competitors

Product	Company	Stage	Hype Score
YH1885L(Revaprazan) + Esomeprazole 20mg + placebo	Yuhan	Phase 2	35
E3810 + E3810 + Placebo	Eisai	Phase 3	40
RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUM	Eisai	Phase 3	40
Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenone	Eisai	Approved	43
ABT-981 + Placebo for ABT-981	AbbVie	Phase 2	35
Omeprazole	AstraZeneca	Phase 3	40
Esomeprazole + Lansoprazole	AstraZeneca	Approved	43
Nexium 20mg + Nexium 10mg	AstraZeneca	Phase 3	47
Omeprazole	AstraZeneca	Phase 3	40
AZD0865	AstraZeneca	Phase 2	35
Esomeprazole + Lansoprazole	AstraZeneca	Approved	43
Esomeprazole + Esomeprazole	AstraZeneca	Approved	43
AZD0865	AstraZeneca	Phase 2	35
esomeprazole magnesium (oral medication)	AstraZeneca	Approved	43
Alendronate Effervescent Oral Tablet	Amgen	Phase 2	35
Omeprazole/sodium bicarbonate	Bausch Health	Approved	37
Vonoprazan	Phathom Pharmaceuticals	Phase 1	23
Vonoprazan + Placebo	Phathom Pharmaceuticals	Phase 2	29
Vonoprazan	Phathom Pharmaceuticals	Pre-clinical	27
Vonoprazan + Placebo	Phathom Pharmaceuticals	Phase 3	34